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Summary
The effects of olanzapine (OLZ) on the viability and functioning of human poly-
morphonuclear cells (PMNs) are clearly opposite to those previously reported for 
clozapine (CLZ). In fact, after 4- or 24-h-treatment with 20-50 μM OLZ, a signifi-
cant inhibition of the respiratory burst in PMNs activated with opsonized zimosan 
or phorbol myristate acetate (PMA) was observed, whereas the burst provoked by 
formyl-methionyl-leucyl-phenylalanine (fMLP) was only inhibited at 50 μM OLZ. 
Under the same conditions, spontaneous apoptosis was accelerated at 20-50 μM 
OLZ, while the exogenous addition of H2O2 resulted in the PMN apoptosis being 
dose-dependently inhibited by OLZ in the entire range of concentrations. However, 
when H2O2 was intracellularly generated by treatment with PMA, the induced 
apoptosis was only decreased at 2 μM OLZ. Absorbance scans revealed that OLZ 
is able to react with equimolar quantities of either H2O2 or HOCl. These results 
suggest that OLZ inhibits both ROS-induced PMN apoptosis and respiratory burst 
due to extracellular scavenging of released ROS.






Apoptosis, cambio estructural y generación reactiva de 
especies reactivas de oxígeno en neutrófilos humanos 
expuestos a olanzapine, una droga antipsicótica atípica
Los efectos de olanzapine (olz) sobre la viabilidad y el funcionamiento de células 
humanas polimorfonucleares (pmn, por sus siglas en inglés) claramente son opuestos 
a los señalados para la clozapine (clz). En efecto, después de 4-24 h de tratamiento 
con 20-50 μM olz, se observó una inhibición significativa del estallido respiratorio 
en pmn activados con zimosan o con forbol acetato miristato, mientras que la inhi-
bición provocada por el formil-metionil-leucil-fenilalanina fue sólo inhibida a 50 
µM de olz. En las mismas condiciones, la apoptosis espontánea se aceleró con 20-50 
μM olz, mientras que la adición exógena de H2O2 dio lugar a la apoptosis de pmn 
en dosis dependiente inhibida por olz en el rango entero de concentraciones. Sin 
embargo, cuando se generó H2O2 intracelular por tratamiento con pma, la apoptosis 
inducida se disminuyó solamente con 2 μM olz. 
Las exploraciones de los espectros de absorbancia revelaron que olz puede reaccionar 
con cantidades equimolares de H2O2 o de HOCL. Estos resultados sugieren que 
olz inhibe ambos tipos de apoptosis de pmn (la inducida por especies reactivas 
oxigenadas y por estallido respiratorio debido a atrapadores extracelulares de estas 
especies reactivas oxigenadas).
Palabras clave: olanzapina, neutrofilos, apoptosis, estallido respiratorio, estrés 
oxidativo.
Introduction
Olanzapine (OLZ) is an atypical anti-schizophrenic drug which is as effective in 
treating positive symptoms as traditional anti-psychotics but has less severe side effects. 
This psychotropic agent belongs to the thienobenzodiazepine class. The chemical 
designation is 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b] [1,5]benzo-
diazepine (Fig. 1). OLZ is used for treating schizophrenia and acute mixed or manic 
episodes associated with bipolar disorder. It also is used as maintenance therapy for 
bipolar disorder and for treating agitation due to schizophrenia or bipolar disorder. 
Although this drug displays antipsychotic efficacy probably by virtue of its dopami-
nergic blocking properties, the specific mechanisms of action whereby OLZ exerts its 
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therapeutic effects remain unknown. Indeed, in recent years it has been suggested that 
for many diseases of the central nervous system, the most effective drugs have affin-
ity for many molecular targets. For instance, recent studies have indicated that OLZ 
protects PC12 pheochromocytoma cells against both N-methyl-4-phenylpyridinium 
ion- and H2O2-induced apoptosis (Qing et al. 2003, Wei 2003). These findings are in 
line with the notion that the pathogenesis of schizophrenia may be related to oxida-
tive stress (Herken 2001). Moreover, in a recent report we showed that clozapine, an 
OLZ-related atypical neuroleptic drug, can rescue PMNs from spontaneous apoptosis 
in vitro (Vargas et al. 2005). It has been proposed that this type of apoptosis, which 
represents a classical example of death occurring as a result of the removal of a sur-
vival signal, probably ensues as a consequence of the intracellular generation of reactive 
oxygen species (Scheel-Toellner et al. 2004). To complicate things further, clozapine 
also induced an increased generation of reactive oxygen species (ROS) after treatment 
of PMNs with receptor-dependent stimuli, whereas the degree of enhancement was 
negligible upon subsequent exposure to receptor-independent activators. 
Figure 1. Structure of Olanzapine (OLZ).
Previous reports have shown that the antipsychotic drug olanzapine (OLZ) can pro-
tect PC12 pheochromocytoma cells against oxidative stress-induced apoptosis. In 
addition, the OLZ-structurally related antipsychotic drug clozapine (CLZ) primed 




These findings suggest that the atypical antipsychotic class of drugs appears to have 
a generalized protective effect against apoptosis.The in vitro study reported here was 
carried out to assess whether OLZ at 2-50 µM could alter neutrophil oxidative burst, 




zepine, molecular formula C17H20N4S, with a molecular weight of 312.44 gr/mol, was 
extracted from the commercial medicine Ziprexa® (Eli Lilly laboratory, United King-
dom) with a soxhlet extractor using ethanol as the solvent, purified by TLC and recrys-
tallized from the same solvent. Purity was determined as 99% by mass spectroscopy and 
1H-NMR. Phorbol myristate acetate (PMA), formyl-methionyl-leucyl-phenylalanine 
(fMLP), glucose oxidase (from Aspergillus niger, 18000 units/g) and luminol, were 
purchased from Sigma (St Louis, USA). A 0.01 M hydrogen peroxide solution was 
freshly prepared by a dilution of 30% hydrogen peroxide with distilled water. Hank´s 
balanced salt solution (HBSS) was prepared by dissolving the commercially available 
powdered medium (Sigma). Before use, 0.1% (w/v) gelatin was added (HBSS-gel). 
Isolation of human PMNs
After informed consent, venous blood was obtained from healthy volunteer donors. 
Neutrophils were isolated from EDTA-anticoagulated blood following a differential 
centrifugation method previously described (Eggleton et al. 1989). The separated cells 
were suspended to 1 x 107/mL of HBSS.
Cell culture and treatment 
To evaluate long-term effects (24 h) of OLZ, human PMNs (final concentration: 5 x 
106 cells/mL) suspended in a RPMI 1640 medium (pH 7.4) supplemented with 10% 
fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin and 100 μg/mL streptomycin, 
were incubated for different time periods with OLZ (2-50 μM) or solvent (DMSO; 
final concentration: 1% v/v) at 37°C in an atmosphere containing 5% CO2. In other 
experiments, OLZ-treated PMNs were incubated with PMA or a glucose-glucose oxi-
dase mixture for the doses and times indicated.
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Neutrophil chemiluminescence
Samples for neutrophil chemiluminescence determinations were prepared by adding 
50 μL of the olanzapine-treated neutrophil suspensions in RPMI to HBSS supplemen-
ted with luminol (total volume: 700 μL. Final concentrations: 3.6 x 105 neutrophils/
mL, 52 μM luminol). Chemiluminescence was measured in a Bio-Orbit 1251 lumi-
nometer (Labsystems Oy, Helsinki, Finland) using 4-mL polypropylene tubes. The 
tubes were equilibrated for 5 min at 37 ºC after which 50 μL of opsonized zymosan 
(OZ; final concentration: 0.21 mg/mL), or 2.4 μL of PMA (final concentration: 0.22 
μM) were added. The light emission was recorded for 30 s intervals and its intensity 
was determined by integrating the area under the chemiluminescence curve (in mV.s) 
during 30 min. 
Opsonization of zymosan
Zymosan was boiled in isotonic NaCl for 1 h, washed three times by centrifugation, 
and suspended (3 mg/mL) in HBSS. Opsonization was carried out by incubating 1 vol 
of the above suspension with 1 vol of fresh human serum for 30 min at 37°C and then 
washing three times with HBSS before dividing in aliquots and keeping at -80°C until 
use (Kroes et al. 1992).
Neutrophil shape change
Neutrophil shape change was assessed by optical microscopy. At 4 or 24 h, neutrophil 
suspensions treated with OLZ were pelleted, resuspended in RPMI at 5 x 106/mL, and 
incubated for 15 min in the presence of 0.1 μM fMLP at 37°C and 5% CO2. The cells 
were then fixed in 2% glutaraldehyde, and assessed morphologically as either “shape 
changed” or spherical.
Assessment of neutrophil apoptosis by morphological examination
For morphological assessment, 150 μL of pretreated neutrophils (5 x 106 cells/mL) 
were spun down (120g, 6 min) onto glass slides using a cyto-centrifuge (Hermle, Z 
323 K, Germany). The slides were air-dried and stained with Wright-Giemsa solution 
for light microscopic evaluation. The percentage of cells with characteristic apoptotic 
changes (nuclear condensation, vacuolation and blebbing) was assessed by counting at 
least 300 cells/slide with the use of a 40X objective (Axiolab, Zeiss, Germany).
Flow Cytometric Determination of Apoptosis in Neutrophils by Annexin V/
Propidium Iodide Double Staining
This assay was adapted with some modifications from (McNamee et al. 2005). Briefly, 
venous blood was collected in a heparinized vacutainer tube (BD Biosciences, San Jose, 
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CA). Whole blood from each donor was diluted 1:10 with RPMI (final leukocyte con-
centration: 0.5-1.0 x 106 cells/mL) and 1 mL fractions were transferred into 10 mm 
culture dish. Olanzapine (final concentration: 2-50 μM) was added to whole blood 
cultures and the cultures were incubated at 37°C and 5% CO2 for 24 h. Then, 1 mL 
aliquots were removed from each culture dish for analysis by flow citometry. To mea-
sure neutrophil apoptosis, 1 mL of diluted blood was added to a flow citometry tube 
and centrifuged at 250 x g. The supernatant was removed and then 1,5 mL of NH4Cl 
lysis solution was added to each tube and incubated at room temperature for 15 min. 
The samples were centrifuged for 6 min at 250 x g and washed two times with 2 mL 
of PBS. The cells were re-suspended in 100 μL of 1x Annexin V binding buffer (BD 
Biosciences, San Jose, CA) and were labeled for detection of apoptotic cells by adding 
5 μL of Annexin V-FITC (BD Biosciences, San Jose, CA). Immediately before analysis 
by flow citometry (FACSCanto, BD Biosciences, San Jose, CA), 2 μL of propidium 
iodide (PI) (1 mg/mL) (BD Biosciences, San Jose, CA) were added to each sample. 
Neutrophils were identified using forward-/side-scatter. Apoptotic cells were identi-
fied as those cells that were Annexin V+. 
Monitoring of the reaction of OLZ with H2O2 and HOCl
Equimolar solutions (100 μM) of OLA and H2O2 or sodium hypochlorite (NaOCl) 
were prepared in PBS pH 6.0 and mixed in quartz cells. Repetitive spectra (200-480 
nm) were measured every 30 s in a UV-Vis Perkin Elmer Lambda 35 spectrophotometer. 
Statistical treatment of results
All values were expressed as the mean ± S.E.M. Data were analyzed using the Student’s 
t-test. Differences were considered to be significant when the p value was <0.05.
Results and discussion
Effects of OLZ on neutrophil viability
To examine the effects of OLZ on PMN viability, isolated cells were incubated for 24 h 
and analyzed by trypan blue exclusion (necrosis) or by Wright-Giemsa staining (apop-
tosis). In addition, to avoid in vitro artifacts related to cell purification and hemolysis, 
the possibility of apoptosis caused by a flow cytometric analysis in whole blood was 
investigated. Figure 2 shows that in isolated neutrophils, cell necrosis was not signifi-
cantly altered (Fig. 2A), whereas spontaneous apoptosis was dose-dependently accele-
rated (Fig. 2B). In contrast, the flow cytometric analysis did not show any significant 
effect (Fig. 2C).   
Biological Events in Human Neutrophils Exposed to Olanzapine
11
Figure 2. Dose-response of OLZ-induced cell death. Percentage of necrosis (A) and apoptosis (B) 
when isolated PMNs (1 x 106/mL) were incubated with medium or with OLZ for 24 h. Necrosis 
was assessed by the trypan blue exclusion method and apoptosis was determined by morphological 
observation. Percentage of apoptotic neutrophils in whole blood as measured by flow citometry 
(C). The data represent the mean ± S.E.M. from four different experiments. Statistical analysis was 
done by comparing incubations containing different concentrations of the drug with the diluent 
control: *P < 0.05; ***P<0.001, paired with Student’s test.
Effects of OLZ on functional capabilities of human neutrophils
Luminol-enhanced chemiluminescence (LCL) was used to evaluate receptor-depen-
dent (OZ, fMLP)- and receptor-independent (PMA)-induced ROS formation in 
PMNs treated with OLZ during 4 or 24 h in the 0-50 μM range. These activators 
were selected because constitutive PMN apoptosis is accompanied by decreased supe-
roxide generation following receptor-dependent stimuli whereas apoptotic PMNs pre-
serve their superoxide production when activated with receptor-independent stimuli 
(Whyte et al. 1993). Figure 3 shows that in PMNs activated with OZ or PMA after 
treatment during 4 or 24 h, the LCL was significantly decreased. However, in fMLP-
activated PMNs, the LCL was only inhibited at 50 μM OLZ, independently of the 
incubation times. Besides, the dose-response profile was clearly different from that 
observed with the other stimuli. 
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Figure 3. Effect of different concentrations of OLZ on CL response of human PMNs (final concen-
tration: 3.6 x 105 /mL) incubated for 4 h or 24 h before activation with OZ (0.21 mg/mL), PMA 
(0.22 μM) or fMLP (0.57 μM). Data are means from eight healthy donors ± SEM. The areas under 
the CL vs. time curves were calculated over a time period of 30 min (OZ, PMA) or 6 min (fMLP). 
Significance with respect to control: *P < 0.05; **P < 0.01; ***P<0.001, paired with Student’s test.
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In ROS-producing cells such as PMNs, superoxide (O2
-) is generated by a NADPH 
oxidase from dioxygen and dismutated to H2O2 by superoxide dismutase (SOD). 
Hydrogen peroxide can be metabolized to hypochlorite (OCl-) by myeloperoxidase 
(MPO) or converted to hydroxyl radical (HO.) by Haber-Weiss or Fenton reactions 
(Fialkow et al. 2007). These active oxygen species enhance LCL (Dahlgren and Karlsson 
1999). On the other hand, it has been shown that fMLP-stimulated LCL of PMNs 
predominantly reflects the generation of hydroxyl radical (HO.) while PMA- and OZ-
stimulated LCL mostly reflects the formation of hypochlorite (OCl-) and/or singlet 
oxygen (1O2) (Takahashi et al. 1991). Additionally, the attenuation of LCL in PMNs 
stimulated by either OZ or PMA suggests that a direct reaction of OLZ and H2O2 
or OCl- may occur. We examined this possibility by recording the UV spectra during 
the OLZ-H2O2 and OLZ-OCl
- reactions. Figure 4 shows that the addition of H2O2 
or OCl- caused marked changes in the absorption spectrum of OLZ, a result which is 
indicative of the formation of new products. 
Figure 4. Absorbance scans of OLZ (100 μM) incubated with H2O2 (100 μM). The scans shown in 
this figure are about 30 s apart.
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In a previous report we noted the interesting result that using OZ- or fMLP as stimuli, 
there was a substantially enhanced LCL response in PMNs treated with 20-50 µM clo-
zapine, whereas the degree of enhancement was negligible upon subsequent exposure 
to PMA (Vargas et al. 2005). It is worth noting that, in the absence of an activating 
peroxidase, clozapine was not oxidized after mixture of the drug with H2O2, suggesting 
there was no direct chemical reaction between the two substances (Gardner et al. 1998).
Neutrophil polarization is a characteristic change in cell shape in response to a chemo-
tactic stimulus such as fMLP. Figure 4 shows that the OLZ-treated PMNs generate 
complex responses when stimulated with 10 μM fMLP. For instance, in the 4 h-in-
cubation assay, 2 μM OLZ induced a slight increment in cell polarization whereas in 
the 20-50 μM range, a dose-dependent inhibition was evident. In contrast, in the 24 
h-incubation, no inhibition was observed. Indeed, at 20 μM OLZ, a statistically signi-
ficant stimulation occurred, suggesting a protective effect. Although not significant, 
this effect was also observed at 20 μM OLZ in the fMLP-stimulated chemilumines-
cence (Fig. 5). Clearly, when OLZ-treated PMNs are activated by fMLP, the results 
obtained, whether in chemiluminescence or in shape change assays, are rather puzzling 
and difficult to interpret. 
Figure 5. Effects of preincubation for 4-24 h with OLZ on neutrophil (final concentration: 3.6 x 
105/mL) morphology changes in response to fMLP (0.1 μM). Mean ± SEM of 5 experiments. Sig-
nificance with respect to control: *P < 0.05; **P < 0.01; ***P<0.001, paired with Student’s test.
Effects of OLZ on apoptosis in PMA- or H2O2-treated neutrophils
To determine whether OLZ could alter neutrophil apoptosis induced by intracellu-
larly generated hydrogen peroxide, we used a protocol that includes a brief period (30 
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min) of incubation with PMA followed by washing with medium and re-incubation 
for 180 min. It had previously been demonstrated that treatment with PMA leads to 
intracellular H2O2 production, whereas non-apoptotic death was minimized through 
washing with culture medium (Lundqvist-Gustafsson and Bengtsson 1999). Figure 
6A indicates that PMA induced a marked apoptotic effect on PMNs when compared 
with cells treated with medium alone (P<0.001, N = 5), whereas in cells co-incubated 
with 2 μM OLZ, a modest inhibition of apoptosis was observed. In addition, parallel 
experiments carried out by the trypan blue exclusion method showed that OLZ did 
not affect the percentage of cell that died.
To elucidate the exact mechanism by which some drugs such as clozapine and OLZ 
induce neutropenia or lethal agranulocytosis, many experiments have been conducted 
to study their oxidation behavior in the presence of an added activating system (horse-
radish peroxidase or myeloperoxidase) plus H2O2 or NaOCl (Gardner et al. 1998, 
Kohara et al. 2002). However, in our study we were interested in examining how sus-
ceptible the PMNs are to H2O2 in the absence of peroxidases. Thus, to evaluate the 
effects of OLZ on PMNs treated with exogenous H2O2, a bolus of H2O2 was added 
directly to the cells. However, a considerable degree of variability with respect to PMN 
viability was observed (data not shown). In contrast, when the cells were exposed to 
a low but continuous supply of H2O2 through its enzymatic generation by glucose 
and glucose oxidase, the results were much easier to reproduce. Figure 6B shows that 
this treatment induced a significant apoptotic effect on PMNs when compared with 
medium alone (P<0.001, N = 5) whereas pre-incubation with 2-50 μM OLZ inhib-
ited this effect in a dose-dependent fashion, without affecting cell membrane integrity. 
Again, the attenuation of H2O2-induced apoptosis in human neutrophils by OLZ may 
at least partly result from its ROS-scavenging effects. Similar results were obtained 
when H2O2-treated PC12 cells were exposed to OLZ for 24 h at concentrations of 
100 μM or more (Wei et al. 2003), further suggesting that the OLZ-H2O2 reaction 
does not generate toxic products. 
In the presence of OLZ and isolated neutrophils, cell necrosis was not significantly 
altered, whereas spontaneous apoptosis was dose-dependently accelerated, but the 
flow cytometric analysis did not show any significant effect. 
The disparate findings (Figure 2) may be attributed to the use of purified PMNs versus 
the use of a whole blood assay with the added presence of various cytokines and other 
cell types. Alternatively, it is possible that the presence of albumin or other competi-
tive agents in the whole blood may explain the absence of OLZ effects on neutrophil 
apoptosis. Indeed, an early report showed that in vivo, OLZ is predominantly bound 
to albumin and alpha-1-acid glycoprotein (Callaghan et al. 1999). 
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Figure 6. Effects of OLZ on neutrophil death after treatment with PMA (A) or glucose-glucose oxi-
dase (B). In (A), the cells were exposed to OLZ for 5 min before treatment with 0.05 μM PMA or 
medium only, and then washed and reincubated for 3 h. In (B), the OLZ-treated cells (1 x 106/mL) 
were exposed to 40 milliunits/mL of glucose oxidase (GOx), which generates approx. 1.2 nmol of 
H2O2 per mL/min for 6 h. Thereafter, cells were stained with Wright-Giemsa after cytocentrifugation 
(apoptosis) or with trypan blue (necrosis). Mean ± SEM of 4 experiments Significance with respect 
to PMA- or GOx-treated control cells: *P < 0.05; **P < 0.01; ***P<0.001, paired with Student’s test.
The results obtained from both chemiluminescence assays and absorbance scans sug-
gest that OLZ inhibits neutrophil apoptosis only extracellularly. A direct chemical 
reaction between H2O2 and OLZ could account for these findings. Besides, the effects 
of OLZ on both spontaneous neutrophil apoptosis and the respiratory burst clearly 
contrasts with those previously reported for clozapine. At this point, we do not know 
whether these contrasting effects may be related to the differences in therapeutic and 
toxic properties of olanzapine and also clozapine.
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PMA induced a marked apoptotic effect on PMNs when compared with cells treated 
with medium alone, whereas in cells co-incubated with 2 μM OLZ, a modest inhibi-
tion of apoptosis was observed. Further studies on biological systems will contribute to 
elucidating this behaviour.
Conclusion
Our results indicate that OLZ is able to inhibit neutrophil apoptosis mediated by 
extracellularly added H2O2 but not by intracellularly generated H2O2. Further investi-
gations are necessary to determine the effects of the presence of OLZ, applied to other 
PMN functions such as chemotaxis, degranulation and phagocytosis and also on other 
biological systems. In conclusion, OLZ is an interesting anti-schizophrenic drug that 
may act through mechanisms unique to itself to exert its apoptotic action on human 
polymorphonuclear cells.
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